Mirati Therapeutics reported $122.08M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acceleron Pharma XLRN:US $ 57.37M 2.11M
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Amgen AMGN:US $ 14842M 257M
Astellas Pharma 4503:JP Y 554768M 26812M
AstraZeneca AZN:LN 23649M 1427M
Bayer BAYN:GR € 28727M 801M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Eisai 4523:JP Y 280829M 2895M
Eli Lilly And LLY:US $ 13682M 1411.2M
Exelixis EXEL:US $ 269.51M 14.18M
Gilead Sciences GILD:US $ 10245M 31M
GlaxoSmithKline GSK:LN 22417M 1030M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Moderna Inc MRNA:US 9.96B 1.12B
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Novartis NOVN:VX SF 29880M 247M
Puma Biotechnology PBYI:US $ 116.26M 21.64M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Seattle Genetics SGEN:US $ 698.43M 264.6M
Spectrum Pharmaceuticals SPPI:US $ 57.27M 0.57M
Takeda 4502:JP Y 1918750M 273984M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
YTE INCY:US $ 742.71M 82.39M